Prepared for NCT07024563

Unlock the power to be your own CRO.

Go beyond your protocol and create an operations plan with Polytrial, the AI-powered platform for research professionals. Leverage insights from thousands of reference trials and fix operations issues before they derail your study. Polytrial saves you time and money, without an army of consultants.

Operations analysis report

Study title

Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)

NCT#

NCT04469465

Last updated

May 4, 2025

10 recommendations found

Clinical Research Coordinator Analysis

Drug Administration and Dietary Adherence for RMC-4630

Finding: The protocol (Sections 7.1 "Investigational Product Administration" and 8.7.3 "Dietary Instructions") mandates that RMC-4630 be administered with a "low-fat meal (approximately 10-15 grams of fat)". However, it lacks specific examples of qualifying meals or clear, standardized instructions for site staff on how to counsel participants effectively and how to document participant adherence to this dietary requirement. This ambiguity presents a practical challenge for CRCs in providing consistent patient education and for sites in accurately capturing compliance, potentially leading to variability in drug absorption and an increase in data queries. Recommendation: Request the Sponsor to develop and provide a supplementary site-facing guidance document or a protocol appendix. This document should include: 1) A list of common, easily accessible food items or simple meal examples that align with the "10-15 grams of fat" criterion. 2) Standardized, patient-friendly talking points for CRCs/site staff to use when counseling participants on adhering to this specific meal type. 3) A clear, simple, and standardized method for documenting participant-reported adherence in source documents and subsequently in the CRF (e.g., a checkbox for "Low-fat meal consumed as instructed: Y/N" based on patient report at the visit, or guidance for a brief dietary recall note specifically for the RMC-4630 administration). Rationale: Providing these resources will significantly enhance participant understanding and consistent adherence to the dietary instructions. This, in turn, will promote uniformity in drug administration conditions across all participants and sites, minimize potential variability in RMC-4630 pharmacokinetics due to dietary deviations, and streamline site documentation processes, ultimately reducing the risk of protocol deviations, data inconsistencies, and subsequent queries related to drug administration.

Operations analysis report

Clinical Research Coordinator Analysis

Drug Administration and Dietary Adherence for RMC-4630

Finding: The protocol (Sections 7.1 "Investigational Product Administration" and 8.7.3 "Dietary Instructions") mandates that RMC-4630 be administered with a "low-fat meal (approximately 10-15 grams of fat)". However, it lacks specific examples of qualifying meals or clear, standardized instructions for site staff on how to counsel participants effectively and how to document participant adherence to this dietary requirement. This ambiguity presents a practical challenge for CRCs in providing consistent patient education and for sites in accurately capturing compliance, potentially leading to variability in drug absorption and an increase in data queries. Recommendation: Request the Sponsor to develop and provide a supplementary site-facing guidance document or a protocol appendix. This document should include: 1) A list of common, easily accessible food items or simple meal examples that align with the "10-15 grams of fat" criterion. 2) Standardized, patient-friendly talking points for CRCs/site staff to use when counseling participants on adhering to this specific meal type. 3) A clear, simple, and standardized method for documenting participant-reported adherence in source documents and subsequently in the CRF (e.g., a checkbox for "Low-fat meal consumed as instructed: Y/N" based on patient report at the visit, or guidance for a brief dietary recall note specifically for the RMC-4630 administration). Rationale: Providing these resources will significantly enhance participant understanding and consistent adherence to the dietary instructions. This, in turn, will promote uniformity in drug administration conditions across all participants and sites, minimize potential variability in RMC-4630 pharmacokinetics due to dietary deviations, and streamline site documentation processes, ultimately reducing the risk of protocol deviations, data inconsistencies, and subsequent queries related to drug administration.

We know Alexion Pharmaceuticals, Inc. is already a research leader. Explore how Polytrial could have helped with past studies.

Overwhelmed by the operations side of research? Polytrial can help.

Congrats on posting NCT07024563! We understand the hard work behind every clinical trial and the obstacles that stand in your way. From innovative treatments blocked by operations breakdowns, to spiraling budgets and software that makes things worse, to the endless back-and-forth to get your team on the same page. Even the best researchers can use help breaking through.

Real-time operational insights

Real-time operational insights

Visual workflow modeling

Visual workflow modeling

GxP tracking

GxP tracking

Improve your operations in three simple steps

Today

Today

Today

Schedule an operations consultation

Take the first step towards a successful trial by discussing your protocol and any existing operating procedures and policies. We'll lay the foundation to translate your scientific design into an actionable, real-world study plan. We value your confidentiality and frequently enter NDAs to protect potential partners. You can request an NDA [here](Common Paper link).

2 weeks

2 weeks

2 weeks

Start your operations plan buildout

Once we aligned on your needs, Polytrial gets to work. We use a mix of expert operations professionals and an AI-powered study team to find and fix potential bottlenecks. We'll visualize all workflows, generate critical operational insights, and simulate stakeholder feedback to design a robust and efficient trial.

1 month

1 month

1 month

Launch confidently & optimize continuously

With Polytrial as your guide, easily manage study updates and protocol amendments, ensuring continuous alignment across your team. Quickly activate and train new sites with intuitive, version-controlled workflows, proactively identifying and resolving issues to keep your study on track and save time and money.

FAQ

What is Polytrial?

Who should use Polytrial?

How does Polytrial work?

What are the platform’s key features?

How do you use artificial intelligence?

How is Polytrial different?

Is Polytrial self-serve?

Can Polytrial integrate with existing systems?

Want to learn more?
Schedule an operations consultation

Find & fix bottlenecks in minutes

© 2024 Polytrial Corp.

Find & fix bottlenecks in minutes

© 2024 Polytrial Corp.

Find & fix bottlenecks in minutes

© 2024 Polytrial Corp.